• Blog

February 2021 News/Events

Keywords: MIDD, monthly newsletter, SLP MIDD+ Virtual Conference
Software: DDDPlus™, DILIsym®, GastroPlus®, IPFsym®
Division: Clinical Pharmacology and Pharmacometrics (CPP), PBPK, Quantitative Systems Pharmacology (QSP)

MIDD++ Model informed drug development 2021 virtual conference

 

Hear LIVE from Modeling & Simulation experts | March 3rd & 4th

New York

Cognigen

strategic implementation of model-informed drug development (MIDD) for regulatory success

 

Feb. 11- Learn how-to achieve optimal benefit from data-driven and informed internal decision making.

REGISTER HERE

North Carolina

DILIsym

DILIsym and IPFsym a platform to support the development of effective treatments for the IPD patients

 

Feb.18 – Find out how IPFsym™ can be used to support the development of effective treatments for IPF patients.

REGISTER HERE

California

Simulations Plus

GastroPlus standards update and documentation project

 

Feb.24 – DDI webinar: including NEW mechanisms added to Midazolam, Ketoconazole, Gemfibrozil, and Rifampicin

RELEASE NOTES

France

Lixoft

easy sharing of your simulx project

 

Simulx is an intuitive, flexible, and powerful application to simulate new situations and answer “what if” questions.

STREAM HERE

MIDD+ march third and fourth model informed drug development

Copyright © 2021 Simulations Plus, All rights reserved.

Simulations Plus, Inc. Corporate Headquarters
42505 10th Street West
Lancaster, CA 93534
Telephone: +1-661-723-7723

Cognigen Corporation, a Simulations Plus company
1780 Wehrle Drive, Suite 110
Buffalo, NY 14221-7000
Telephone: +1-716-633-3463

DILIsym Services, a Simulations Plus company
Six Davis Drive
PO Box 12317
Research Triangle Park, NC 27709
Telephone: +1-919-558-1323

Lixoft, a Simulations Plus company
8 rue de la Renaissance Batiment D
92160 Antony, France
Telephone: +33 9 72 53 91 80